跳至主要内容
临床试验/NL-OMON42836
NL-OMON42836撤回2 期

An investigation of the Effect of Long-Term Electrical Stimulation on Esophageal Acid Exposure in Pediatric Patients with Gastroesophageal Reflux Disease (GERD) - Effect of electrical stimulation on GERD in pediatric patients.

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • a) Subject is between 5 * 16 years of age.
  • b) Subject has a history of heartburn, regurgitation or both for >6 month prompting physician recommendation of continual daily use of PPI before study entry.
  • c) Subject who are on standard medical therapy for 6 months or longer and experience discomfort or who are otherwise dissatisfied with GERD symptoms.
  • d) Subjects with a GERD condition that in the opinion of the PI justifies a minimally invasive reversible procedure prior to attempting anatomical change such as Nissen or Toupet fundoplication.
  • e) Subject has exhibited excessive lower esophageal acid exposure during 24-hour pH-metry of antisecretory therapy performed within 6 months of screening visit; pH < 4 for > 5% of total time.
  • f) Subject has a resting LES end expiratory pressure * 5mmHg on manometry performed within 6 months of enrollment.
  • g) Subject has no esophagitis or esophagitis * Grade C (LA classification) on upper endoscopy within 6 months of enrollment.
  • h) Subject*s body weight >15kg.
  • i) Subject*s BMI <30 kg/m2.
  • j) Subject*s parent or legal guardian (and subject from age 12) has signed the informed consent form and is able to adhere to study visit schedule.

排除标准

  • a) Subject has known non-GERD esophageal motility disorder that in the opinion of investigator precludes an anti-reflux procedure.
  • b) Subject has history of gastroparesis.
  • c) Subject has any history of significant multisystem diseases (e.g. kidney failure, liver failure).
  • d) Subject has a known autoimmune or a connective tissue disorder (e.g. scleroderma, dematomyositis, Calcinosis-Raynaud*s-Esophagus Sclerodactyly Syndrome (CREST), Sjogren*s Syndrome, Sharp*s Syndrome) requiring therapy in the preceding 2 years.
  • e) Subject has Barrett*s epithelium (> M2; >C1) or any grade of dysplasia.
  • f) Subject has a hiatal hernia larger than 3 cm.
  • g) Subject has a body mass index (BMI) greater than 30 kg/m2.
  • h) Subject has Type 1 diabetes mellitus.
  • i) Subject has uncontrolled Type 2 diabetes mellitus (T2DM) defined as HbA1c >9.5 in the previous 6 months, or has T2DM for > 10 years.
  • j) Subject has a history of suspected or confirmed esophageal or gastric cancer.
  • k) Subject has esophageal or gastric varices.
  • l) Subject has significant cardiac arrhythmia or ectopy or significant cardiovascular disease.
  • m) Subject has an existing implanted electrical stimulator (e.g., pacemaker, AICD).
  • n) Subject requires chronic anticoagulant therapy.
  • o) Subject has dysphagia due to eosinophilic esophagitis, esophageal peptic stricture, excluding Schatzki*s ring.
  • p) Subject of child-bearing potential who is pregnant or intends to become pregnant during the trial period.
  • q) Subject is currently enrolled in other potentially confounding research.
  • r) History of any malignancy in the last 2 years.
  • s) History of previous surgery involving the LES, excluding Nissen and Toupet fundoplication.
  • t) Subject has any condition that, at the discretion of the investigator or sponsor, would preclude participation in the trial.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验

An investigation of the Effect of Long-Term... | 临床试验